Floatz logo

Pancrelipase

Digestive System Diseases

Mylan Inc.mixtureDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Digestive System Diseases cohort.

Asset / SponsorPhaseRating
Empagliflozin
Yonsei University
Phase 4BB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Cedars-Sinai Medical Center
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Cedars-Sinai Medical Center
Phase 4BB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB

View all 44 →

Same molecule, other indications

Pancrelipase is also rated in:

exocrine pancreatic insufficiencyDormant
A
Indicative ·
80 / 100
View asset →
cystic fibrosisDormant
BB
Indicative ·
69 / 100
View asset →
chronic pancreatitisDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →